TrademarkDir
EPIVAX ONCOLOGY
DEAD

Serial Number

87561735

Owner

EPIVAX ONCOLOGY, INC.

Attorney

Cheryl A. Clarkin

First Use Date

Sep 11, 2019

Filing Date

Aug 9, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EPIVAX ONCOLOGY Trademark

Serial Number: 87561735 • Registration: 5938527

EPIVAX ONCOLOGY is a trademark filed by EPIVAX ONCOLOGY, INC. on August 9, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

EPIVAX ONCOLOGY, INC. (5 trademarks)

Providence, RI 02909

Entity Type: 03

EpiVax, Inc. (12 trademarks)

146 Clifford Street
Providence, RI 02903

Entity Type: 03

EPIVAX THERAPEUTICS, INC. (4 trademarks)

188 VALLEY STREET, SUITE 424
PROVIDENCE, RI 02909

Entity Type: 03

Trademark Details

Filing Date

August 9, 2017

Registration Date

December 17, 2019

First Use Anywhere

September 11, 2019

First Use in Commerce

September 11, 2019

Published for Opposition

March 27, 2018

Cancellation Date

July 3, 2026

Goods & Services

Medical research services in the field of cancer, namely, computational processing of cancer and normal protein sets

Medical analysis services for the treatment of cancer, namely, analysis of cancer and normal protein sets

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 3, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 17, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 21, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 21, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 21, 2022 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 9, 2022 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 14, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 13, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 12, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 12, 2019 AITU
USE AMENDMENT FILED
Oct 30, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 30, 2019 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 30, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 30, 2019 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2019 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 10, 2019 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2019 EXRA
SOU EXTENSION 2 GRANTED
Apr 18, 2019 EX2G
SOU EXTENSION 2 FILED
Apr 18, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 18, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2018 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2018 TCCA
SOU EXTENSION 1 GRANTED
Oct 31, 2018 EX1G
SOU EXTENSION 1 FILED
Oct 31, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 31, 2018 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 29, 2018 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 22, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 27, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 27, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2018 CRFA
ASSIGNED TO LIE
Feb 14, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2017 REAP
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Nov 15, 2017 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Nov 15, 2017 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Nov 15, 2017 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Nov 15, 2017 CPEA
ASSIGNED TO EXAMINER
Nov 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2017 NWOS
NEW APPLICATION ENTERED
Aug 12, 2017 NWAP

Related Trademarks

More from this Owner

EPIVAX THERAPEUTICS

EPIVAX THERAPEUTICS

EPIVAX THERAPEUTICS

EPIVAX THERAPEUTICS

EPIVAX THERAPEUTICS

EPIVAX THERAPEUTICS

ANCER

ANCER

ANCER

ANCER

ANCER

ANCER